A congressional subcommittee questioned CDC and FDA officials over efforts to monitor adverse events that may still manifest from original COVID-19 vaccines.
A congressional subcommittee questioned CDC and FDA officials over efforts to monitor adverse events that may still manifest from original COVID-19 vaccines.